Palisade Bio, Inc. (PALI) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 466.1% |
| FCF Growth (YoY) | 9.5% |
| Price / Book | 3.02 |
| Price / Sales | 735.42 |
| Sector P/E (Healthcare) | 21.7 |
PALI overview · PALI earnings · PALI KPIs · PALI investor relations · PALI ownership · PALI peers · PALI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.